Spots Global Cancer Trial Database for Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions
Official Title: A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Anastrozole 1 mg Tablets Under Fed Conditions
Study ID: NCT01155089
Conditions
Interventions
Study Description
Brief Summary: The objective of this study was to prove the bioequivalence of Anastrozole Tablet under fed conditions
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Bio-Kinetic Clinical Applications, Springfield, Missouri, United States
Contact Details
Name: Dennis Morrison, D.O.
Affiliation: Bio-Kinetic Clincial Applications
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
